Concepedia

Adaptive Bayesian Dosing

Adaptive Bayesian Dosing is a Bayesian dosing framework that dynamically refines individualized drug dosage regimens by sequentially updating pharmacokinetic parameter estimates as new therapeutic drug monitoring data become available.

21

Publications

1.5K

Citations

127

Authors

41

Institutions

Publications per year

2017–2026

5

Parents

Publications

21

Maintenance therapy with low‐dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome

Marcos de Lima, Sergio Giralt, Peter F. Thall et al. · Cancer · 2010 · 429 citations · Full text

, , +17

Impact of Goal-Oriented and Model-Based Clinical Pharmacokinetic Dosing of Aminoglycosides on Clinical Outcome: A Cost-Effectiveness Analysis

Nicolette A. E. M. van Lent-Evers, Ron A. A. Mathôt, W. P. Geus et al. · Therapeutic Drug Monitoring · 1999 · 246 citations

, , +17

Suramin, an Active Drug for Prostate Cancer: Interim Observations in a Phase I Trial

Mario A. Eisenberger, L. M. Reyno, D. I. Jodrell et al. · JNCI Journal of the National Cancer Institute · 1993 · 131 citations

, , +17

ASTIN: a Bayesian adaptive dose–response trial in acute stroke

Andrew P. Grieve, Michael Krams · Clinical Trials · 2005 · 85 citations

, , +17

Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer.

Mario A. Eisenberger, Victoria J. Sinibaldi, Leonard Reyno et al. · Journal of Clinical Oncology · 1995 · 80 citations

, , +17

1–5 of 21

Authors

127

  1. JC
    Joseph Ciccolini

    Aix-Marseille Université, France

    4 publications · 144 citations

    4

    h-index

  2. SM
    Suzanne Monjanel‐Mouterde

    Hôpital de la Timone, France

    4 publications · 144 citations

    4

    h-index

  3. RF
    Roger Favre

    Hôpital de la Timone, France

    3 publications · 119 citations

    3

    h-index

  4. BP
    Bertrand Pourroy

    Hôpital de la Timone, France

    3 publications · 119 citations

    3

    h-index

  5. AD
    Alain Durand

    Centre National de la Recherche Scientifique, France

    3 publications · 104 citations

    3

    h-index

1–5 of 127

Institutions

41

  1. Hôpital de la Timone

    Marseille, France

    3 h-index

    9 publications

    263 citations

  2. University of Southern California

    Los Angeles, United States

    3 h-index

    8 publications

    314 citations

  3. Roche (Switzerland)

    Basel, Switzerland

    3 h-index

    11 publications

    177 citations

  4. University of Maryland, Baltimore

    Baltimore, United States

    2 h-index

    8 publications

    997 citations

  5. University of Michigan

    Ann Arbor, United States

    2 h-index

    3 publications

    489 citations

  6. Pfizer (United States)

    New York, United States

    2 h-index

    2 publications

    114 citations

  7. University of Miami

    Coral Gables, United States

    1 h-index

    1 publications

    429 citations

  8. PRA Health Sciences

    Raleigh, United States

    1 h-index

    1 publications

    14 citations

1–8 of 41

Venues

  1. Therapeutic Drug Monitoring

    5 publications · 334 citations

    5

    h-index

  2. Journal of Clinical Oncology

    2 publications · 122 citations

    2

    h-index

  3. Clinical Trials

    1 publications · 85 citations

    1

    h-index

  4. Inflammatory Bowel Diseases

    1 publications · 75 citations

    1

    h-index

  5. Anti-Cancer Drugs

    1 publications · 55 citations

    1

    h-index

1–5